A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Severe to Very Severe Alopecia Areata in Adult Patients (Rezolve AA)
Public ClinicalTrials.gov record NCT06340360. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2b, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Rezpegaldesleukin in the Treatment of Severe to Very Severe Alopecia Areata in Adult Patients (Rezolve AA)
Study identification
- NCT ID
- NCT06340360
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Nektar Therapeutics
- Industry
- Enrollment
- 94 participants
Conditions and interventions
Conditions
Interventions
- Rezpegaldesleukin Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 1, 2024
- Primary completion
- Nov 25, 2025
- Completion
- Jul 31, 2026
- Last update posted
- Jul 9, 2026
2024 – 2026
United States locations
- U.S. sites
- 10
- U.S. states
- 9
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Nektar Investigative Site | Northridge | California | 91324 | — |
| Nektar Investigative Site | Atlanta | Georgia | 30331 | — |
| Nektar Investigative Site | Gurnee | Illinois | 60031 | — |
| Nektar Investigative Site | Indianapolis | Indiana | 46202 | — |
| Nektar Investigative Site | Clinton Township | Michigan | 48038 | — |
| Nektar Investigative Site | Portsmouth | New Hampshire | 03801 | — |
| Nektar Investigative Site | New York | New York | 10075 | — |
| Nektar Investigative Site | Camp Hill | Pennsylvania | 17011 | — |
| Nektar Investigative Site | Frisco | Texas | 75034 | — |
| Nektar Investigative Site | Pflugerville | Texas | 78660 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 16 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06340360, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 9, 2026 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06340360 live on ClinicalTrials.gov.